Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Miravitlles

Showing results (111-120 of 564) with videos related to

Pageof 57
Sort By:
Archivos De Bronconeumologia|July 15, 2019
Clinical Control in COPD: A New Therapeutic Objective?Juan José Soler-Cataluña, Bernardino Alcázar, Marc Miravitlles
Archivos De Bronconeumologia|May 26, 2022
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based StudyMònica Monteagudo, Alexa Nuñez, Miriam Barrecheguren, et al.
Tuberculosis and Respiratory Diseases|June 22, 2018
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same?Marc Miravitlles, Seungjae Baek, Vatsal Vithlani, et al.
Archivos De Bronconeumologia|November 29, 2023
Reply to Figueroa-Gonçalves and de Miguel-DíezMarc Miravitlles, Konstantinos Kostikas, Nikoletta Bizymi, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 22, 2019
Time To Revise COPD Treatment AlgorithmKazuto Matsunaga, Keiji Oishi, Marc Miravitlles, et al.
Respiration; International Review of Thoracic Diseases|July 23, 2011
Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary diseaseMarc Miravitlles, Karlos Naberan, Jordi Cantoni, et al.
Chest|March 12, 2003
Costs of chronic bronchitis and COPD: a 1-year follow-up studyMarc Miravitlles, Cristina Murio, Tina Guerrero, et al.
Drug Discovery Today|September 4, 2014
Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotypingPaolo Montuschi, Mario Malerba, Giuseppe Santini, et al.
COPD|July 27, 2017
Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?Matevz Harlander, Miriam Barrecheguren, Matjaz Turel, et al.
Archivos De Bronconeumologia|June 24, 2023
A Novel Figure and Algorithm for the Gold ABE ClassificationMarc Miravitlles, Konstantinos Kostikas, Nikoletta Bizymi, et al.
Pageof 57

Showing results (111-120 of 564) with videos related to

Sort By:
Pageof 57
Archivos De Bronconeumologia|July 15, 2019
Clinical Control in COPD: A New Therapeutic Objective?Juan José Soler-Cataluña, Bernardino Alcázar, Marc Miravitlles
Archivos De Bronconeumologia|May 26, 2022
Effectiveness of Treatment With Dual Bronchodilation (LABA/LAMA) Compared With Combination Therapy (LABA/ICS) for Patients With COPD: A Population-Based StudyMònica Monteagudo, Alexa Nuñez, Miriam Barrecheguren, et al.
Tuberculosis and Respiratory Diseases|June 22, 2018
Optimal Bronchodilation for COPD Patients: Are All Long-Acting β₂-Agonist/Long-Acting Muscarinic Antagonists the Same?Marc Miravitlles, Seungjae Baek, Vatsal Vithlani, et al.
Archivos De Bronconeumologia|November 29, 2023
Reply to Figueroa-Gonçalves and de Miguel-DíezMarc Miravitlles, Konstantinos Kostikas, Nikoletta Bizymi, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 22, 2019
Time To Revise COPD Treatment AlgorithmKazuto Matsunaga, Keiji Oishi, Marc Miravitlles, et al.
Respiration; International Review of Thoracic Diseases|July 23, 2011
Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary diseaseMarc Miravitlles, Karlos Naberan, Jordi Cantoni, et al.
Chest|March 12, 2003
Costs of chronic bronchitis and COPD: a 1-year follow-up studyMarc Miravitlles, Cristina Murio, Tina Guerrero, et al.
Drug Discovery Today|September 4, 2014
Pharmacological treatment of chronic obstructive pulmonary disease: from evidence-based medicine to phenotypingPaolo Montuschi, Mario Malerba, Giuseppe Santini, et al.
COPD|July 27, 2017
Should Patients Switched from D to B in the GOLD 2017 Classification be Discontinued from Inhaled Corticosteroids?Matevz Harlander, Miriam Barrecheguren, Matjaz Turel, et al.
Archivos De Bronconeumologia|June 24, 2023
A Novel Figure and Algorithm for the Gold ABE ClassificationMarc Miravitlles, Konstantinos Kostikas, Nikoletta Bizymi, et al.
Pageof 57